IRIS
SOLIMANDO, ANTONIO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.585
AS - Asia 4.249
EU - Europa 3.230
SA - Sud America 1.133
AF - Africa 266
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.476
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.387
SG - Singapore 1.841
BR - Brasile 894
IT - Italia 870
CN - Cina 791
HK - Hong Kong 503
RU - Federazione Russa 447
SE - Svezia 414
DE - Germania 409
VN - Vietnam 357
FR - Francia 343
GB - Regno Unito 221
IN - India 160
FI - Finlandia 153
CA - Canada 102
ID - Indonesia 93
BD - Bangladesh 76
AR - Argentina 71
CI - Costa d'Avorio 67
ZA - Sudafrica 60
MX - Messico 58
IQ - Iraq 56
TR - Turchia 56
PL - Polonia 55
JP - Giappone 50
NL - Olanda 46
CO - Colombia 43
ES - Italia 43
PK - Pakistan 38
BE - Belgio 37
CZ - Repubblica Ceca 36
AT - Austria 31
VE - Venezuela 30
UA - Ucraina 28
EC - Ecuador 27
EG - Egitto 26
MA - Marocco 26
PH - Filippine 26
SA - Arabia Saudita 26
LT - Lituania 25
KR - Corea 24
JO - Giordania 22
TN - Tunisia 22
UZ - Uzbekistan 22
MY - Malesia 20
CL - Cile 19
PY - Paraguay 17
IE - Irlanda 16
KE - Kenya 16
AE - Emirati Arabi Uniti 15
ET - Etiopia 14
AU - Australia 10
NP - Nepal 10
PE - Perù 10
BO - Bolivia 9
DZ - Algeria 9
IR - Iran 9
UY - Uruguay 8
CH - Svizzera 7
KW - Kuwait 6
LB - Libano 6
PA - Panama 6
AO - Angola 5
HU - Ungheria 5
JM - Giamaica 5
NI - Nicaragua 5
OM - Oman 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DK - Danimarca 4
HR - Croazia 4
IL - Israele 4
NO - Norvegia 4
RS - Serbia 4
SR - Suriname 4
SY - Repubblica araba siriana 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
PT - Portogallo 3
QA - Qatar 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BF - Burkina Faso 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
GM - Gambi 2
GR - Grecia 2
HT - Haiti 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MG - Madagascar 2
ML - Mali 2
MT - Malta 2
Totale 16.439
Salva come PNG Salva come JPEG
Città #
Singapore 1.088
Ashburn 1.085
Chandler 605
Fairfield 570
San Jose 545
Hong Kong 497
Nyköping 341
Woodbridge 304
Beijing 259
Houston 253
Seattle 251
Cambridge 233
New York 227
Ann Arbor 201
Bari 195
Los Angeles 195
Wilmington 176
Council Bluffs 164
Lauterbourg 147
Dallas 137
Munich 114
Ho Chi Minh City 110
Helsinki 109
Dearborn 100
Roxbury 93
Lawrence 92
Falkenstein 84
Marseille 84
São Paulo 82
Des Moines 71
Abidjan 67
Jakarta 67
Hanoi 65
Rome 65
Brooklyn 64
Frankfurt am Main 62
Moscow 60
Santa Clara 59
Chicago 57
Buffalo 52
London 46
San Diego 45
Tokyo 45
Nanjing 44
Boardman 43
Orem 43
Inglewood 40
Johannesburg 40
Dong Ket 39
Brussels 37
Turku 36
Denver 35
Montreal 34
Toronto 33
Warsaw 32
Milan 31
Paris 31
Stockholm 29
Chennai 27
Brno 26
Atlanta 24
Jacksonville 24
Manchester 24
Poplar 24
Nuremberg 23
Phoenix 23
Redwood City 23
The Dalles 22
Baghdad 21
Rio de Janeiro 21
Amman 20
Boston 20
Tashkent 20
Guangzhou 19
Mexico City 19
Princeton 19
Washington 19
Campinas 18
San Francisco 18
Columbus 17
Salt Lake City 17
Shanghai 17
Curitiba 16
Dublin 16
Haiphong 16
Leawood 16
Dhaka 15
Amsterdam 14
Augusta 14
Belo Horizonte 14
Elk Grove Village 14
Mumbai 14
Pune 14
Salvador 14
Shenyang 14
Tampa 14
Brasília 13
Cairo 13
Kunming 13
Addis Ababa 12
Totale 10.474
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 292
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 243
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 216
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 216
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 209
B-Cell Therapies in Relapsing Remitting and Primary Progressive Multiple Sclerosis: A Short Clinical Review 184
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 181
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 180
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 179
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 177
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 176
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 176
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 175
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 175
Microenvironment drug resistance in multiple myeloma: Emerging new players 171
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 171
Targeting B-cell non Hodgkin lymphoma: New and old tricks 168
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 166
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 161
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 159
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 156
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 155
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 151
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 149
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 149
Bortezomib treatment modulates autophagy in multiple myeloma 148
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features 147
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment 143
A comprehensive biological and clinical perspective can drive a patient-tailored approach to multiple myeloma: Bridging the gaps between the plasma cell and the neoplastic niche 142
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 139
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 137
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 137
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 136
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 134
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 133
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man: Approach to the Patient Between Guidelines and Clinical Judgment 132
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 132
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 131
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 131
Angiogenesis and Antiangiogenesis in Multiple Myeloma 131
Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach 131
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta‐analysis of eight studies 130
Actors on the scene: Immune cells in the myeloma niche 128
Amyloid heart involvement lead a fast fatal evolution a healthy woman: a case report 128
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 128
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement 124
CIC-Mutation As a Potential Molecular Mechanism of Acquired Resistance to Combined BRAF/MEK Inhibition in CNS Multiple Myeloma 124
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 122
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 122
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 122
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 120
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 119
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS 118
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 117
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research 116
Proangiogenic effect of bone marrow fibroblasts in patients with multiple myeloma 116
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm 115
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions 114
Antibiotic treatment in vasculitic leg ulcers: a single center experience 112
Fever, cough and breathlessness in a patient with digeorge syndrome 111
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 111
Sonography of superficial lymph nodes in malignant lymphomas. Data from our case series. 109
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 107
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 106
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 105
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 104
Two-year follow-up after drug desensitization in mucopolysaccharidosis 103
A Challenging Case of Visceral Leishmaniasis 103
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 100
Rituximab induces a reduction of lymphocyte CD3+ activated in patients with autoimmune diseases 99
Real-life experience with omalizumab in chronic spontaneous urticaria. 97
Prognostic role of neoplastic markers in Takotsubo syndrome 97
An atypical presentation of intestinal neuroendocrine tumor. 96
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma 94
Telemedicine DSS-AI Multi Level Platform for Monoclonal Gammopathy Assistance 94
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 94
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 92
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 92
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 91
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 90
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow 89
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 89
Rituximab use in autoimmune diseases: a single center experience. 88
Immune system and bone microenvironment: rationale for targeted cancer therapies 88
A Markov model for estimating the cost-effectiveness of immunotherapy for newly diagnosed multiple myeloma patients 88
Difference in growth hormone response to growth hormone-releasing hormone (GHRH) testing following GHRH subacute treatment in normal aging and growth hormone-deficient adults: Possible perspectives for therapeutic use of GHRH or its analogs in elderly subjects? 87
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 86
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme 86
The anti-vegf(R) drug discovery legacy: Improving attrition rates by breaking the vicious cycle of angiogenesis in cancer 86
Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside 86
Changes in Angiogenesis and Bone Turnover Markers in Patients with Gaucher Disease Developing Osteonecrosis 86
Genomic profiling at a single center cracks the code in inborn errors of immunity 85
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 85
The bone marrow niche landscape: a journey through aging, extrinsic and intrinsic stressors in the haemopoietic milieu 85
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 84
Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation 84
Worldwide prevalence, genotype distribution and management of hepatitis C 84
Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis 83
CARDIOVASCULAR RISK SCORE MAY BE USEFUL IN STRATIFY DEATH RISK IN HOSPITALIZED COVID19 PATIENTS 82
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 81
Totale 12.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.959
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021348 0 0 0 0 0 0 0 0 0 129 90 129
2021/2022941 79 36 30 33 40 84 38 50 76 82 135 258
2022/20231.550 155 220 128 123 145 170 43 186 280 26 50 24
2023/2024866 48 121 54 76 75 258 32 21 20 24 16 121
2024/20253.613 150 57 172 130 134 313 538 355 160 220 522 862
2025/20267.304 1.066 374 498 903 1.019 483 904 312 1.033 712 0 0
Totale 17.403